Infectious Disease
Navigating COVID-19 in Patients with Comorbidities: Cardiovascular Diseases
Cardiovascular disease is a comorbidity that puts individuals at higher risk for developing COVID-19 and experiencing post-infection complications. This program describes the impact of COVID-19 in people with pre-existing cardiovascular disease, the relationship between COVID-19 and cardiovascular complications, and NACI recommendations for the COVID-19 primary series and COVID-19 vaccine booster doses.
DURATION
20 min
PROFESSION
Physician, Nursing, Pharmacy, Allied Health, Medical Resident, Student, Specialist
# OF CREDITS
0
ACCREDITATION
Unaccredited
EXPIRY DATE
2024-05-12
Cardiovascular disease is a comorbidity that puts individuals at higher risk for developing COVID-19 and experiencing post-infection complications. This program describes the impact of COVID-19 in people with pre-existing cardiovascular disease, the relationship between COVID-19 and cardiovascular complications, and NACI recommendations for the COVID-19 primary series and COVID-19 vaccine booster doses.
Note: This expert brief was recorded on May 4th, 2023.
This program has received funding from Moderna Biopharm Canada Inc.
Faculty
Elizabeth Swiggum, MD, FRCPC, FCCS
Kim Connelly, MBBS, PhD, FCCS, FSCMR
Learning objectives
Upon completion of this continuing education video, participants will be better able to:
- Describe the burden of COVID-19 on individuals with pre-existing cardiovascular disease.
- Discuss the relationship between COVID-19 and cardiovascular complications.
- Review NACI recommendations for the COVID-19 primary series and COVID-19 vaccine booster doses.